Back to search

National and Kapodistrian University of Athens

Ποσοτική μέτρηση του πεπτιδίου ενδοθηλίνη -1 στη φλεβική και αρτηριακή κυκλοφορία διασωληνωμένων ασθενών με νόσο Covid-19

Abstract

dc:description

The COVID-19 pandemic (2019-2022) has prompted rapid mobilization from the scientific community to clarify the pathogenesis of acute respiratory distress syndrome (ARDS) in COVID-19. Clinical data indicate that COVID-19 often presents as a syndrome of acute respiratory distress caused by viral pneumonia (ARDS) in patients with pre-existing endothelial dysfunction due to multiple comorbidities (hypertension, coronary artery disease, respiratory diseases, diabetes), while obesity and male gender are additional exacerbating factors. Similarly, advanced age has been identified as one of the main risk factors for developing severe clinical disease due to the SARS-CoV-2 virus. The endothelium is a cell layer lining the inner surface of blood vessels (arteries, veins, capillaries) and the heart. It plays a crucial role in regulating vascular permeability, blood flow, coagulation, vasoconstriction, vasodilation, and the body’s response to inflammatory conditions. Additionally, it actively participates in the process of angiogenesis. As such, endothelial dysfunction is linked to many diseases, such as hypertension, atherosclerosis, and other cardiovascular diseases. Endothelin (ET-1) is a potent vasoconstrictor protein primarily produced by endothelial cells, which line the inner surface of blood vessels. In healthy pulmonary circulation, the production rate of endothelin-1 is nearly identical to its clearance rate. The objective of the proposed Doctoral Dissertation is the quantification of endothelin-1 peptide levels in the venous and arterial circulation, as well as the assessment of its metabolism (clearance) in pulmonary function, in relation to the clinical deterioration of intubated patients suffering from Acute Respiratory Distress Syndrome (ARDS) due to COVID-19 infection. More specifically, the levels of endothelin-1 were studied in intubated patients with a confirmed diagnosis of SARS-CoV-2 (RT-PCR test), as well as the arterial-to-venous endothelin-1 ratio (A:V). This approach allowed us to indirectly calculate the metabolism of endothelin-1 in patients with ARDS and COVID-19, aiming to explore the potential link between elevated levels or dysregulated clearance of endothelin-1 in the pulmonary circulation and poor prognosis in patients with Acute Respiratory Distress Syndrome (ARDS) and COVID-19 disease. The need for recording these data, particularly the long-term outcomes, arises from the lack of corresponding international clinical and laboratory records that correlate endothelin-1 peptide levels and its metabolism in the pulmonary circulation with the clinical course of intubated patients with acute respiratory distress syndrome in the context of COVID-19 infection.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Roumpaki, Anastasia
  • Ρουμπάκη, Αναστασία

Subjects

dc:subject × 23

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59105

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Roumpaki, Anastasia; Ρουμπάκη, Αναστασία. Ποσοτική μέτρηση του πεπτιδίου ενδοθηλίνη -1 στη φλεβική και αρτηριακή κυκλοφορία διασωληνωμένων ασθενών με νόσο Covid-19. National and Kapodistrian University of Athens, 2025. http://hdl.handle.net/10442/hedi/59105